Doctor Panagiotis Orfanos
Novartis Pharma AG, Basel, Switzerland, Basel (Switzerland)
Follow
Contributor content
Journal
Review on clinical strategies for managing patients with elevated Lp(a): Cost-effectiveness of Lp(a) testing and awareness of lifestyle changes via Public Health Policy in absence of targeted therapy
28 July 2023
